BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22194989)

  • 21. Characterization of the human cysteinyl leukotriene 2 receptor.
    Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
    J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.
    Jiang Y; Borrelli LA; Kanaoka Y; Bacskai BJ; Boyce JA
    Blood; 2007 Nov; 110(9):3263-70. PubMed ID: 17693579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.
    Neves JS; Radke AL; Weller PF
    J Allergy Clin Immunol; 2010 Feb; 125(2):477-82. PubMed ID: 20159258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils.
    Thivierge M; Doty M; Johnson J; Stanková J; Rola-Pleszczynski M
    J Immunol; 2000 Nov; 165(9):5221-6. PubMed ID: 11046055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.
    Lau WK; Chow AW; Au SC; Ko WH
    PLoS One; 2011; 6(7):e22363. PubMed ID: 21799837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
    Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
    Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy.
    Barajas-Espinosa A; Ni NC; Yan D; Zarini S; Murphy RC; Funk CD
    FASEB J; 2012 Mar; 26(3):1100-9. PubMed ID: 22131271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
    Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
    J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
    Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
    Barrett NA; Fernandez JM; Maekawa A; Xing W; Li L; Parsons MW; Austen KF; Kanaoka Y
    J Immunol; 2012 Nov; 189(9):4556-65. PubMed ID: 23002438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells.
    Yudina Y; Parhamifar L; Bengtsson AM; Juhas M; Sjölander A
    Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):223-31. PubMed ID: 19042113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
    Maekawa A; Kanaoka Y; Lam BK; Austen KF
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
    Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
    Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
    Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and functional aspects of human cysteinyl leukotriene receptors.
    Capra V
    Pharmacol Res; 2004 Jul; 50(1):1-11. PubMed ID: 15082024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
    Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
    Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
    Sarau HM; Ames RS; Chambers J; Ellis C; Elshourbagy N; Foley JJ; Schmidt DB; Muccitelli RM; Jenkins O; Murdock PR; Herrity NC; Halsey W; Sathe G; Muir AI; Nuthulaganti P; Dytko GM; Buckley PT; Wilson S; Bergsma DJ; Hay DW
    Mol Pharmacol; 1999 Sep; 56(3):657-63. PubMed ID: 10462554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors.
    Zhang WP; Hu H; Zhang L; Ding W; Yao HT; Chen KD; Sheng WW; Chen Z; Wei EQ
    Neurosci Lett; 2004 Jun; 363(3):247-51. PubMed ID: 15182953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion.
    Profita M; Sala A; Bonanno A; Siena L; Ferraro M; Di Giorgi R; Montalbano AM; Albano GD; Gagliardo R; Gjomarkaj M
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1024-30. PubMed ID: 18305014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
    Maekawa A; Austen KF; Kanaoka Y
    J Biol Chem; 2002 Jun; 277(23):20820-4. PubMed ID: 11932261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.